Botulinum toxin A for the treatment of delayed gastric emptying

American Journal of Gastroenterology

Volumn 103, Issue 2, 2008, Pages 416-423

  Friedenberg, Frank K ^a,b,c   Palit, Amiya ^a   Parkman, Henry P ^a   Hanlon, Alexandra ^b   Nelson, Deborah B ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; CISAPRIDE; DOMPERIDONE; ERYTHROMYCIN; METOCLOPRAMIDE; PLACEBO; PROTON PUMP INHIBITOR; TEGASEROD;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION ROUTE; FATIGUE; FEMALE; FOLLOW UP; GASTROPARESIS CARDINAL SYMPTOM INDEX; HEADACHE; HUMAN; INTRAPYLORIC DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STOMACH EMPTYING; STOMACH PARESIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE;

BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; FEMALE; GASTRIC EMPTYING; GASTROPARESIS; HUMANS; INJECTIONS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PYLORUS;

EID: 39049102889     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01676.x     Document Type: Article

References (24)

1. Parkman H, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004 127 : 1592 622.
2. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology 2006 131 : 640 58.
3. Malagelada JR, Rees WDW, Mazzotta LJ, et al. Gastric motor abnormalities in diabetic and post-vagotomy gastroparesis: Effect of metoclopramide and bethenachol. Gastroenterology 1980 78 : 286 93.
4. Camilleri M, Brown ML, Malagelada JR. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 1986 91 : 94 9.
5. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986 90 : 1919 25.
6. Friedenberg FK, Parkman HP. Management of delayed gastric emptying. Clin Gastroenterol Hepatol 2005 3 : 642 6.
7. Sturm A, Holtmann G, Goebell H, et al. Prokinetics in patients with gastroparesis: A systemic analysis. Digestion 1999 60 : 422 7.
8. Erbas T, Varoglu E, Erbas B, et al. Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis. Diabetes Care 1993 16 : 1511 4.
9. Soykan I, Sarosiek I, McCallum RW. The effect of chronic oral domperidone on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 1997 92 : 976 80.
10. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991 324 : 1186 94.
11. Miller LS, Szych GA, Kantor SB, et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002 97 : 1653 60.
12. Ezzeddine D, Jit R, Katz N, et al. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 2002 55 : 920 3.
13. Lacy BE, Crowell MD, Schettler-Duncan A, et al. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 2004 27 : 2341 7.
14. Lacy BE, Zayat EN, Crowell MD, et al. Botulinum toxin for the treatment of gastroparesis: A preliminary report. Am J Gastroenterol 2002 97 : 1548 52.
15. Arts J, van Gool S, Caenepeel P, et al. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Aliment Pharmacol Ther 2006 15 : 661 7.
16. Bromer MQ, Friedenberg F, Miller LS, et al. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005 61 : 833 9.
17. Arts J, Caenepeel P, Degreef T, et al. Randomised double-blind cross-over study evaluating the effect of intrapyloric injection of botulinum toxin on gastric emptying and symptoms in patients with gastroparesis. Gastroenterology 2005 128 : A544.
18. Arts J, Bisschops R, Caenepeel P, et al. A placebo-controlled crossover study of intrapyloric injection of botulinum toxin in diabetic or postsurgical gastroparesis. Gastroenterology 2007 132 : A779.
19. Revicki DA, Rentz AM, Dubois D, et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: The Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003 18 : 141 50.
20. Guo JP, Maurer AH, Urbain JL. Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 2001 46 : 24 9.
21. Bouvet L, Duflo F, Bleyzac N, et al. Erythromycin promotes gastric emptying during acute pain in volunteers. Anesth Analg 2006 102 : 1803 8.
22. Reynolds JC, Putnam PE. Prokinetic agents. Gastroenterol Clin North Am 1992 21 : 567 96.
23. Annese V, Bassotti G, Coccia D, et al. A multicenter randomised study of intrasphinteric botulinum toxin in patients with oesophageal achalasia. Gut 2000 46 : 597 600.
24. Vittal H, Pasricha PF. Botulinum toxin for gastrointestinal disorders: Therapy and mechanisms. Neurotox Res 2006 9 : 149 59.